Class II · Moderate risk
Herpes V Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
FDA Drug Recalls
832 recalls, newest first
Class II · Moderate risk
Herpes Soap
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes-G
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Hernia Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Hair Back Lotion
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Hair Back Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Lotion
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Flare Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fire Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Edema Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dragon Pain Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Detoxin-S
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Detoxin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
DeTensin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermatoxin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermamycin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
De-Fibroidin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Cellulite Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Blood Clot Purger
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Bleeding Stop
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asthma Chest Rub
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs